Insider Transactions in Q1 2021 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,070
+0.36%
|
$33,170
$31.74 P/Share
|
|
Mar 31
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+12.65%
|
$3,906
$31.74 P/Share
|
|
Mar 31
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+12.98%
|
$4,588
$31.74 P/Share
|
|
Mar 31
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
952
+1.26%
|
$29,512
$31.74 P/Share
|
|
Mar 31
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,188
+1.02%
|
$36,828
$31.74 P/Share
|
|
Mar 31
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
216
+0.21%
|
$6,696
$31.74 P/Share
|
|
Mar 22
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
744
+50.0%
|
-
|
|
Mar 22
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
744
+46.85%
|
-
|
|
Mar 11
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
796
-0.48%
|
$25,472
$32.82 P/Share
|
|
Mar 10
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
21,960
-11.59%
|
$702,720
$32.97 P/Share
|
|
Mar 10
2021
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,480
-7.05%
|
$559,360
$32.97 P/Share
|
|
Mar 10
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,361
-6.84%
|
$235,552
$32.97 P/Share
|
|
Mar 10
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
12,461
-10.12%
|
$398,752
$32.97 P/Share
|
|
Mar 10
2021
|
Paul Herendeen EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,519
-13.34%
|
$1,904,608
$32.97 P/Share
|
|
Mar 10
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
231,188
-18.19%
|
$7,398,016
$32.97 P/Share
|
|
Mar 08
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
25,980
+12.06%
|
-
|
|
Mar 08
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,455
+4.92%
|
-
|
|
Mar 08
2021
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,144
+10.2%
|
-
|
|
Mar 08
2021
|
Thomas Appio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,161
+4.0%
|
-
|
|
Mar 08
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,530
+11.17%
|
-
|
|
Mar 08
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,404
+4.47%
|
-
|
|
Mar 08
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
17,320
+12.33%
|
-
|
|
Mar 08
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
5,637
+5.06%
|
-
|
|
Mar 08
2021
|
Paul Herendeen EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
50,518
+10.17%
|
-
|
|
Mar 08
2021
|
Paul Herendeen EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,324
+11.09%
|
-
|
|
Mar 08
2021
|
Joseph C Papa Director |
BUY
Grant, award, or other acquisition
|
Direct |
108,254
+7.85%
|
-
|
|
Mar 08
2021
|
Joseph C Papa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
317,089
+21.42%
|
-
|
|
Mar 03
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
36,250
+18.95%
|
-
|
|
Mar 03
2021
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,626
+13.41%
|
-
|
|
Mar 03
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,298
+10.31%
|
-
|
|
Mar 03
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
23,892
+19.26%
|
-
|
|
Mar 03
2021
|
Paul Herendeen EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
63,439
+15.48%
|
-
|
|
Mar 03
2021
|
Joseph C Papa Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,150
+8.06%
|
-
|
|
Mar 03
2021
|
Robert Spurr President, U.S. Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
23,892
+28.71%
|
-
|
|
Mar 01
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
5,367
-4.32%
|
$166,377
$31.42 P/Share
|
|
Mar 01
2021
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,436
-2.96%
|
$168,516
$31.42 P/Share
|
|
Mar 01
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,739
-2.15%
|
$53,909
$31.42 P/Share
|
|
Mar 01
2021
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
3,313
-4.16%
|
$102,703
$31.42 P/Share
|
|
Mar 01
2021
|
Paul Herendeen EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,755
-5.28%
|
$488,405
$31.42 P/Share
|
|
Mar 01
2021
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
28,192
-3.52%
|
$873,952
$31.42 P/Share
|
|
Mar 01
2021
|
Robert Spurr President, U.S. Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
3,252
-8.4%
|
$100,812
$31.42 P/Share
|